Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder

Journal of the American Board of Family Practice

Volumn 17, Issue 4, 2004, Pages 235-239

  Cox, Daniel J ^a,b   Humphrey, Jeffery W ^a   Merkel, R Lawrence ^a   Penberthy, Jennifer Kim ^a   Kovatchev, Boris ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CAR DRIVING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; HUMAN; MALE; ATTENTION; DRUG ADMINISTRATION; DRUG EFFECT; IMPULSIVENESS; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STANDARD; TREATMENT OUTCOME;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTOMOBILE DRIVING; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; TREATMENT OUTCOME;

EID: 16644366827     PISSN: 08938652     EISSN: 15448770     Source Type: Journal    
DOI: 10.3122/jabfm.17.4.235     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
2. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1990;29:546-57.
3. Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry 1985;42:937-47.
4. Liebson CL, Katusic SK, Barbaresi WJ, Ransom J, O'Brien PC. Use and costs of medical care for children and adolescents with and without attention deficit/hyperactivity disorder. JAMA 2001;286:60-6.
5. Jensen PS, Shervette RE, Xenakis SN, Bain MW. Psychosocial and medical histories of stimulant-treated children. J Am Acad Child Adolesc Psychiatry 1988;27:798-801.
6. DiScala C, Lescohier I, Barthel M, Li G. Injuries to children with attention deficit/hyperactivity disorder. Pediatrics 1998;102:1415-21.
7. Barkley RA, Guevremont DC, Anastopoulos AD, DuPaul GJ, Shelton TL. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 1993;92:212-8.
8. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996;98:1089-95.
9. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis 2000;188:230-4.
10. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Comp Psychiatry 1996;37:393-401.
11. Shader RI, Harmatz JS, Oesterheld JR, Parmelee DX, Sallee FR, Greenblatt DJ. Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder. J Clin Pharmacol 1999;39:775-85.
12. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-86.
13. Swanson J, Gupta S, Guinta D, et al. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 1999;66:295-305.
14. Cox DJ, Merkel RL, Penberthy JK, Kovatchev B, Hankin CS. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 2004;43:269-75.
15. Swanson J, Gupta S, Lam A, et al. Development of a new once-a-day formulation of methylphenidate for the treatment of ADHD: proof of concept and proof of product studies. Arch Gen Psychiatry 2003;60:204-11.
16. DuPaul G, Power T, Anastopoulos A, Reid R. ADHD rating scale-IV. New York: Guilford Press; 1998.
17. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 2000;39:28-38.
18. Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 2nd ed. New York: Guilford Press; 1998.
19. Biederman J. Practical considerations in stimulant drug selection for the attention-deficit/hyperactivity patient - efficacy, potency and titration. Today's Therapeutic Trends 2002;20:311-28.
20. Hunt DK, Lowenstein SR, Badgett RG, Steiner JE. Safety belt nonuse by internal medicine patients: a missed opportunity in clinical preventive medicine. Am J Med 1995;98:343-8.